ITGAV and cancer: Furthermore, EpCAM+ITGAV+ cancer cells from mixed cSCCs exhibit a hybrid E/M phenotype and a higher ability to switch to the mesenchymal state than EpCAM+ITGAV− cancer cells, demonstrating the value of ITGAV as a biomarker for identifying epithelial plastic cancer cells within a heterogeneous population of epithelial cancer cells.